Copyright
©The Author(s) 2016.
World J Gastroenterol. Nov 21, 2016; 22(43): 9515-9524
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9515
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9515
Figure 1 Macroscopical score of dextran sulfate sodium-induced colitis in C57BL/6 mice (A-D).
Macroscopical score (MS) of was calculated as described in the Materials and Methods. SB203580 (5 μmol/kg) was injected i.p. twice daily beginning from 60 h after dextran sulfate sodium (DSS) treatment inception and continuing until the last day. WIN55 (5 mg/kg) was administered i.p., once daily for 7 consecutive days, starting from DSS treatment until the end of the experiment. Data of macroscopical parameters are presented as mean ± SEM (n = 8). aP < 0.05 vs control; cP < 0.05 vs DSS + vehicle (Veh). SB: SB203580; WIN: WIN55.
- Citation: Feng YJ, Li YY, Lin XH, Li K, Cao MH. Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK. World J Gastroenterol 2016; 22(43): 9515-9524
- URL: https://www.wjgnet.com/1007-9327/full/v22/i43/9515.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i43.9515